Medical Devices: Page
-
Abbott CEO: ‘We’re right on time’ to the PFA party
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.
By Elise Reuter • Oct. 15, 2025 -
Stereotaxis teams with CardioFocus to develop robotic PFA system
Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ablation.
By Nick Paul Taylor • Oct. 15, 2025 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
5 AI takeaways from AdvaMed’s conference
Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.
By Elise Reuter • Oct. 14, 2025 -
Cybersecurity triggers another recall of J&J’s Impella heart pump controller
While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.
By Nick Paul Taylor • Oct. 14, 2025 -
Intuitive’s challengers continue to advance
Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their progress in this roundup of the latest developments in surgical robotics.
By Susan Kelly • Oct. 10, 2025 -
Zimmer launches 2 devices from $1.1B orthopedic takeover
After acquiring Paragon 28 earlier this year, Zimmer intends to maintain the foot and ankle specialist’s double-digit growth.
By Nick Paul Taylor • Oct. 10, 2025 -
Intuitive expands AI in Ion; Horizon performs first robotic cataract surgery
The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract surgery with its robotic system, and MMI began a neurosurgical study.
By Susan Kelly • Oct. 10, 2025 -
FDA’s presence at AdvaMed conference shrinks amid shutdown
Michelle Tarver, director of the Center for Devices and Radiological Health, and other center officials attended virtually as a government shutdown continues.
By Elise Reuter • Oct. 9, 2025 -
Medtronic begins study of Hugo robot in gynecology
With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on Intuitive Surgical in the U.S. robotic surgery market.
By Susan Kelly • Oct. 9, 2025 -
Owens & Minor inks $375M deal to sell unit to investment firm
The sale will leave Owens & Minor focused on a smaller but potentially faster-growing and higher-margin business that provides products directly to patients.
By Nick Paul Taylor • Oct. 8, 2025 -
AdvaMed CEO: ‘Just give us some certainty’
At AdvaMed’s annual conference, CEO Scott Whitaker addressed policy issues around tariffs, FDA staff cuts and the government shutdown.
By Elise Reuter • Oct. 8, 2025 -
How 4 medtech CEOs are using AI
At AdvaMed’s The MedTech Conference, executives said they’re incorporating AI in more devices, but figuring out how to use the technology internally is challenging.
By Elise Reuter • Oct. 7, 2025 -
Convatec plans $1B investment in R&D in the US and UK
Capacity at the company's Boston site will increase by 50% as part of a $600 million, 10-year commitment to the U.S.
By Nick Paul Taylor • Oct. 7, 2025 -
Sponsored by Arena
How AI-driven supply chain intelligence is transforming medical device manufacturing
AI-powered supply chain intelligence helps MedTech firms overcome EOL risks and regulatory hurdles.
Oct. 6, 2025 -
Q&A
Hospital for Special Surgery’s Ashis Barad says AI must solve real problems
Barad, chief digital and technology officer at HSS, outlined his approach to evaluating AI tools and how the orthopedic hospital uses the technology.
By Elise Reuter • Oct. 3, 2025 -
Medtronic wins CE mark for Penditure LAA exclusion device
The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.
By Nick Paul Taylor • Oct. 3, 2025 -
CDRH shares regulatory guidance priorities for the coming 12 months
Use of real-world evidence to support regulatory decisions and predetermined change control plans for medical devices are two areas of focus for the agency.
By Nick Paul Taylor • Oct. 2, 2025 -
SS Innovations changes course on FDA filing for soft tissue robot
A 510(k) submission now planned for this quarter sets up a potentially faster clearance than the de novo pathway originally planned, the company said.
By Susan Kelly • Oct. 2, 2025 -
Boston Scientific aims for market leadership in electrophysiology
The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for growth.
By Elise Reuter • Oct. 2, 2025 -
Distalmotion adds hysterectomy indication; AiM raises funds for neurosurgical robot
The clearance gives Distalmotion, which sees opportunity in ambulatory settings, a third robotic procedure category in the U.S. Elsewhere, AiM Medical Robotics raised $8.1 million.
By Susan Kelly • Oct. 2, 2025 -
FDA seeks feedback on monitoring real-world performance of AI devices
The agency is looking for ways to detect, assess and mitigate changes to the performance of AI-enabled devices over time.
By Nick Paul Taylor • Oct. 1, 2025 -
Boston Scientific unveils plans for new Watchman device
The company hopes to launch its next-generation Watchman system in the second half of 2027 or early 2028.
By Elise Reuter • Updated Oct. 14, 2025 -
Top medtech conferences in 2026
After a busy first half of the year, there are still plenty of medtech events to look forward to, including AdvaMed’s annual meeting in Boston.
By Ricky Zipp • Updated June 29, 2026 -
FDA expands early alert program to cover all medical devices
After a successful pilot, the agency has lifted the limitations on when it will provide early information about potentially high-risk safety events.
By Nick Paul Taylor • Sept. 30, 2025 -
Medtech firms splitting into ‘haves’ and ‘have-nots’: EY
The number of medtech funding rounds has declined in recent months, but the value of overall deals has increased, according to a new report from EY.
By Elise Reuter • Sept. 29, 2025